Form-boosting drugs claim rocks sport research centre

February 11, 2000

The University of Ferrara, home of Italy's leading centre for medical research related to sports, is at the centre of allegations concerning the use of performance-improving drugs by Italian athletes over the past decade.

According to investigators in the judiciary and on the Italian Olympic Committee, many of the top names in Italian sports, from cycling to cross-country skiing and athletics, made use of recombinant erythropoietin, which enriches red blood cells but cannot be detected by normal drug tests.

The judicial investigation began earlier this year after police raided Ferrara University and seized computer records with the blood test results of hundreds of athletes.

So far, about 20 doctors and researchers have been formally placed under investigation, including Francesco Conconi, head of the sports medicine department at Ferrara University.

Professor Conconi looked after Francesco Moser when he took the one-hour cycling world title in Mexico City in 1984 and helped train Manuela Di Centa, the world champion cross-country skier who retired recently. Many of Italy's top athletes of the mid-1980s to the late 1990s came under the care of Professor Conconi or his assistants at Ferrara.

The city prosecutor is expected to bring charges against the professor and other doctors at the university and possibly against some chemists who allegedly supplied the drug, later this month.

In the late 1980s the Olympic Committee established a partnership with Professor Conconi's biomedical research centre through which it financed his research.

Recombinant erythropoietin, a hormone that stimulates the bone marrow to produce red blood cells far in excess of normal values, was banned by the International Olympic Committee in 1993. It is used to treat anaemia in some serious illnesses, but in a healthy person it increases stamina and resistance to fatigue.

Risks include burst blood vessels and kidney damage. But in statements made so far to both the Olympic Committee and the prosecutor's office, athletes stated that no mention was made of abnormal values when they had their blood tested.

Some of the evidence is based on tapped telephone conversations. A list of 22 athletes who had been treated with recombinant erythropoietin was recently published. The Olympic Committee is investigating the athletes involved in its drive to stamp out drug use in sport, while the prosecutor's office is basing its investigation on the hypothetical crime of administering medication hazardous to health.

You've reached your article limit

Register to continue

Registration is free and only takes a moment. Once registered you can read a total of 6 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments
Register

Have your say

Log in or register to post comments

Featured Jobs

Senior Lecturer in Human Genetics LOUGHBOROUGH UNIVERSITY
Senior Lecturer in Biochemistry LOUGHBOROUGH UNIVERSITY
Lecturer in Biochemistry LOUGHBOROUGH UNIVERSITY
Professor in Marketing UNIVERSITY OF GLASGOW

Most Commented

Artist Frank Boelter sitting in life-size paper boat

Creator of crowdfunding teaching tool says entrepreneurship courses should drop the traditional business plan as a method of assessment

Elly Walton illustration (25 August 2016)

Treating students as consumers has precipitated a rush to the bottom to give them exactly what they want, says John Warren

Superhero costumes hanging on a washing line

Senior management do not recognise support staff’s pivotal role in achieving positive student outcomes, administrators say

Man photocopying a book

Students think it ‘unfair’ to be punished for unintentional plagiarism

Child drives miniature car into people

Smaller, newer alternative providers are less likely to pass higher education review, analysis says